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594a Wednesday, February 11, 2015expressed in both slow skeletal and cardiac muscle. The cTnC HCM muta-
tions A8V, C84Y and D145E increase the Ca2þ-sensitivity of contraction in
cardiac muscle; however, their functional consequences in slow skeletal mus-
cle regulation are unknown. Here we investigated the Ca2þ-sensitivity of
TnC-extracted rabbit soleus skinned fibers reconstituted with either WT or
HCM mutant cTnC. Surprisingly, the slow skeletal skinned fibers extin-
guished the Ca2þ-sensitization typical of cardiac fibers for A8V (pCa50 ¼
6.01) and D145E (pCa50 ¼ 6.05), while for C84Y (pCa50 ¼ 6.33) the
Ca2þ-sensitization was maintained compared to WT (pCa50 ¼ 6.00). To deter-
mine whether slow skeletal TnI (ssTnI) alone was responsible for the protec-
tive effect of incorporating the A8V and D145E mutants into the slow skeletal
myofilaments, cardiac skinned fibers were reconstituted with a hybrid cardiac
troponin complex containing cTnT, ssTnI and cTnC-WT or -HCM mutants.
The presence of ssTnI in cardiac fibers partially protected against Ca2þ-sen-
sitization by the cTnC mutants in cardiac skinned fibers, with the exception
of C84Y. MgATPase activity of slow or cardiac myofibrils replaced with
exogenous HCM cTnC mutants were also affected. The absence of increased
Ca2þ-sensitivity of contraction arising from the A8V and D145E in the soleus
muscle suggests that the aberrant effects of cardiomyopathic cTnCs may be
tissue-specific, and ssTnI is an important partner that partially protects the
slow muscle from a deleterious effect of the HCM cTnC mutants. Supported
by NIH HL103840 (JRP).
2995-Pos Board B425
Structural and Functional Changes in SkeletalMuscles in an A8V-Troponin
C Hypertrophic Cardiomyopathy Knock-In Mouse Model
Milica Vukmirovic1, Marcos Angel Sanchez-Gonzalez2, Gregory S. Frye3,
Andrew Koutnik1, David A. Gonzalez1, Edda Ruiz1, Eric Krivensky1,
David Dweck1, Leonardo F. Ferreira3, Jose Renato Pinto1.
1Biomedical Sciences, Florida State University, Tallahassee, FL, USA,
2Biomedical Sciences, Larkin Health Sciences Institute, South Miami, FL,
USA, 3Applied Physiology and Kinesiology, University of Florida,
Gainesville, FL, USA.
Missense mutations in the TNNC1 gene encoding cardiac and slow skeletal
troponin C (c/ssTnC) are associated with phenotypic outcomes of hypertrophic
cardiomyopathy (HCM). The impact of HCM c/ssTnC mutations in skeletal
muscle structure and function is unknown; therefore, we examined the effect
of an HCM-associated c/ssTnC A8V mutation on myosin heavy chain
(MHC) isoform expression, contractile properties of different skeletal muscles,
and cardiac autonomic function in a homozygous knock-in mouse (KI-TnC-
A8Vþ/þ). The distribution of MHC I/II isoforms in various muscles from
3-month old male WT and KI-TnC-A8Vþ/þ mice were analyzed by glycerol
SDS-PAGE and the muscle/body weight ratios (M/BW) were recorded. Me-
chanics of contraction in isolated intact soleus muscle, running/endurance
capacity and heart rate variability (HRV) were also measured. In comparison
to the WT mice, MHC isoform switching was observed in diaphragm
(increased MHCIIb, decreased MHCI) and soleus (decreased MHCIIa,
increased MHCI) muscles of KI-TnC-A8Vþ/þ mice; while, the M/BW ratio
was unchanged for all tested muscles. The force vs frequency relationship
at 15Hz and the t1/2 of relaxation increased in the intact soleus muscle of KI-
TnC A8Vþ/þ mice in comparison to the WT; whereas, no changes in maximal
force, time-to-twitch peak, velocity and power output were observed. In en-
durance and HRV tests, KI-TnC-A8Vþ/þmice had a lower running distance ca-
pacity and their global autonomic, cardiovagal, and baroreflex activities were
significantly reduced compared to WT. In spite of the increase in type I fibers
in soleus muscle of mice expressing c/ssTnC A8V, they display reduced endur-
ance capacity. These findings suggest that the slow skeletal muscle is trying to
compensate for the cardiac dysfunction caused by the c/ssTnC A8Vþ/þ muta-
tion. Supported by NIH HL103840 (JRP).
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We have implemented two computation versions of the solution actin-myosin
ATPase cycle. A simple numerical model that simulates an eight step
ATPase cycle and allows actin, myosin, substrate ATP and product ADP
& Pi concentrations to be fixed or varied. This model allows us to rapidly
assign realistic rate constants to each step of the cycle for any well-
defined myosin isoform. With this set of rate constants in place we canthen implement a stochastic version of the eight step ATPase cycle that in-
cludes calcium regulation of the actin binding steps according to the McKil-
lop & Geeves Blocked/Closed/Open model of the regulated thin filament.
Using this model it is now feasible to model the dependence of the ATPase
rate on calcium concentration and predict the occupancy of each state in the
cycle for any defined set of protein and substrate concentrations. This allows
us, for example, to explore the interplay of calcium and ATP concentrations
in the cooperative activation of the ATPase cycle and make predictions for
how the system will respond to sudden changes in calcium or ATP concen-
tration. In a further variant of the model the program allows us to predict how
the system will respond if variable ratios of fast and slow isoforms of
myosin, or variable ratios of proteins carrying cardiomyopathy mutations
are present in the system. This will be a useful tool to explore the behaviour
of mixed myosin & troponin populations and correlate experimental data
with model predictions.
Supported by: R01 AR048776, R01 DC 011528 and W.Trust 085309
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We have used site-directed time-resolved FRET to detect structural changes of
the N-terminal extension on the A1 isoform of ELC, during active interaction
with actin. Skeletal muscle myosin subfragment 1 (S1) has two ELC isoforms,
A1 and A2, which differ by the presence of 40-45 additional residues at the
N-terminus of A1. Removal of ELC from myosin results in a loss of movement
of actin filaments, and a reduction in isometric force. It has been proposed that
the N-terminal extension of A1 interacts directly with actin to modulate acto-
myosin kinetics. We have used time-resolved FRET to explore the structural
details of this modulation. We recently showed, using probes on actin and
ELC, that the amplitude of the myosin power stroke is much greater for A1
than A2. We have now engineered single cysteine (C16, in the N-terminal
extension) and double cysteine (C16-C180, in the C-terminal lobe) mutants
of A1-ELC and used FRET to determine the distance from C16 to actin 374
or to C180, as affected by the power stroke. Labeled ELCs were exchanged
into S1, and the pure isoenzyme (S1A1) was isolated using Talon affinity resin.
Labeling and exchange preserved the functional properties of S1A1. Intermo-
lecular FRET between C374 of actin and C16 of A1 showed that the distance
increases from 2.9 nm to 3.5 nm upon addition of ATP. Intramolecular FRET
between C16 and C180 does not change in the presence of ATP or actin. We
conclude that (1) the N-terminus of ELC moves away from actin during the
transition between strongly and weakly bound states of acto-S1, and (2) the
converter/C-terminal domain of myosin/ELC and the N-terminal extension
move as a rigid body during the power stroke.
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The N-terminus of vertebrate fast-type myosin light chain 1 (MLC1F) contains
a conserved actin-binding domain, a nearby poly-alanine (poly-A) domain, and
an adjacent alanine-proline (A-P) repeat domain. The number of residues in the
poly-A and A-P repeat domains vary considerably among vertebrate species.
We reported a strong correlation between the apparent mass of MLC1F and
adult body mass for nineteen mammalian species (Bicer and Reiser, Am. J.
Physiol. Regul. Integr. Comp. Physiol., 292:R527-R534, 2007). The MLC1F
sequence was then known for five of the nineteen species and the variation
in MLC1Fmass was determined to be due largely to the variation in the number
of residues in the poly-A and the number of A-P repeats among these five spe-
cies. We have recently examined the reported MLC1F sequence of additional
mammalian species and of species of other vertebrate classes to determine
the extent of the correlations between the number of poly-A residues and the
number of A-P repeats and body mass among vertebrates, with a particular in-
terest in comparing species with different modes of locomotion (e.g., terrestrial
walking/running versus swimming). We also examined the sequences of other
MLCs for the presence of systematic variations among species and possible
correlations with species body mass. The results reveal that the numbers of
poly-A residues and A-P repeats increase with species body mass among terres-
trial mammals. Furthermore, the MLC1F domains vary most consistently with
adult species body mass than any of the other examinedMLCs. The results sug-
gest that MLC1F domains are likely involved with modulating the speed and/or
economy of locomotion among terrestrial mammals.
